Lexicon Pharmaceuticals LXRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.09M+85.3% | -$50.34M+74.9% | -$68.58M+68.3% | -$120.62M+40.3% | -$177.3M+8.4% | ||
| $555K-1.9% | $621K+16.3% | $628K+12.9% | $603K+3.8% | $566K-3.4% | ||
| $12.55M+2.5% | $12.52M-7.3% | $11.22M-26.1% | $10.58M-35.0% | $12.24M-19.6% | ||
| —— | —— | —— | —— | -$167.43M+9.7% | ||
| $2.18M— | $113.02M— | —— | —— | —— | ||
| $53M— | $48M— | $45M— | $45M— | —— | ||
| $40.83M— | -$48.5M— | —— | —— | —— | ||
| $4.2M— | -$3.33M— | $44.11M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lexicon Pharmaceuticals generate?
- Lexicon Pharmaceuticals (LXRX) generated -$99.6M in operating cash flow over the trailing twelve months.
- Where does Lexicon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
